If you take Ozempic, Wegovy, Mounjaro, Zepbound, or another GLP-1 medication, you have probably seen the phrase “Ozempic teeth” somewhere online. It sounds like the drug is attacking your enamel.
That is not what is happening.
I have spent more than thirty years restoring teeth that failed, and the failures almost never trace back to a single villain. They trace back to an environment. Acidity, saliva, load, and time do the damage. Medications change that environment, and GLP-1 medications change several parts of it at once.
That is worth understanding, especially if you have crowns, veneers, implants, or a full-mouth restoration you intend to keep for decades.
GLP-1 medications are not known to directly damage teeth. They can reduce saliva, trigger reflux and vomiting in some patients, and change eating and hydration patterns. Those shifts make the mouth more acidic and less protected, which raises the risk of decay, erosion, and sensitivity in people who were previously stable.
It is an internet term. It is not a diagnosis, and you will not find it in any dental classification system.
Patients and journalists use it to describe a cluster of complaints: dry mouth, bad breath, new sensitivity, cavities appearing in people who had not had one in years, and altered taste.
The evidence base is genuinely thin. The most-cited clinical report is a 2023 case series of three women who developed severe hyposalivation after six to sixteen weeks on semaglutide, published in Medicine. Their salivary flow recovered with management. Three patients cannot tell us how common this is across millions of users, and the authors said as much.
A 2026 narrative review in the British Dental Journal reached a similar conclusion: prescribing is climbing fast, and the dental literature has not caught up.
So we work with what we do understand well. And what we understand extremely well is saliva.
Saliva is not a comfort feature. It is the mouth’s buffering system.
Per the ADA’s clinical resource on dry mouth, saliva cleanses the oral cavity, protects hard and soft tissue against physical and microbial insult, maintains a neutral pH, and buffers the mucosa against both ingested acid and regurgitated stomach acid. Reduced flow increases the risk of caries, demineralization, sensitivity, and mucosal infection.
The ADA now lists GLP-1 receptor agonists among the medication classes that can contribute to or worsen oral dryness, alongside antihistamines, antidepressants, diuretics, and antihypertensives.
Two details from that same resource matter for how you should think about your own symptoms:
Your symptoms count even if your flow tests normal. Patients can experience genuine dryness while measuring within a normal salivary flow range. If your mouth feels different, that is data.
Nights are worse for a reason. Salivary output hits its circadian low during sleep, and mouth breathing compounds it. If you are waking up with a glass of water beside the bed, that is the window where teeth spend the longest stretch unprotected.
Formally, hyposalivation is defined as unstimulated flow at or below 0.1 mL/min. In practice, I do not wait for a number. I look at whether saliva is pooling on the floor of the mouth, whether the mucosa is sticky, and whether the tongue is dry and fissured.
Signs worth reporting to your dentist: a sticky or burning feeling, needing water constantly, dryness that peaks overnight, altered taste, persistent bad breath, difficulty swallowing dry food, new sensitivity, or cavities appearing despite unchanged hygiene.
GLP-1 medications slow gastric emptying. That is part of how they work. Nausea, vomiting, and reflux are recognized side effects, most common in early weeks and around dose escalation.
Reporting on a SmileCon 2025 session by pharmacist Kimberly Sanders, PharmD, ADA News noted that these gastrointestinal effects can lower oral pH, promoting enamel erosion and shifting the oral microbiome.
Enamel is the hardest tissue in your body and it is chemically defenseless against repeated low pH. Once it dissolves, it does not regenerate. We replace it, which is a different and more expensive proposition.
Erosion also has a signature I can read. Acid from the stomach hits the tongue-side surfaces of the upper front teeth first, which is a very different pattern from the wear I see in someone who grinds. When I see that pattern, I ask about reflux before the patient has usually connected the two.
One practical rule: if you vomit, do not brush immediately. Enamel is softened right after an acid challenge, and a brush is abrasive. Rinse with water, wait, then brush. And if vomiting or reflux is frequent, tell your prescriber. That deserves medical attention independent of what it is doing to your teeth.
Here is where my read differs from most of what you will find online.
A healthy natural tooth in a dry mouth is at risk. A restored tooth in a dry mouth is at risk in more places, because restorations create margins, and margins are where decay starts.
In low-saliva patients, the ADA resource notes that caries tend to appear at root surfaces, cervical areas, and incisal or cuspal tips. Those are precisely the zones that matter to restorative work:
If you have invested in extensive dentistry, a changing oral environment is a bigger deal for you than for someone with a virgin dentition, not a smaller one.
This is the part I would want a patient to bring up before we plan surgery.
In that same ADA News coverage, Dr. Sanders urged clinicians to stay alert to peri-implant health and bone density in patients on these medications, because rapid weight loss may increase bone resorption risk. She also noted that patients with diabetes already face elevated rates of peri-implantitis, delayed healing, and reduced osseointegration.
None of that is a reason to avoid implants. It is a reason for me to know your medication list, your rate of weight loss, and your protein intake before I plan a case that depends on bone integrating around a fixture.
She also flagged two things worth repeating. Early research suggests these medications may slow tooth movement in adults undergoing orthodontic treatment, which matters if your restorative plan includes alignment first. And she recommended avoiding opioid analgesics in these patients where possible, since they worsen gastrointestinal side effects. Relevant if you are facing an extraction or a surgical appointment.
“Ozempic face” is a real observation about facial soft tissue, and it has a consequence almost nobody discusses.
Smile design is not just about teeth. Tooth position, length, and display are planned against lip support, facial volume, and how much you show at rest and in full smile. If your facial soft tissue is actively changing, the frame I am designing against is moving.
[PLACEHOLDER: Dr. Sclafani to add his own position on sequencing here. Example of the shape it should take, to be confirmed or replaced: “In my practice I would rather complete provisional work during active weight loss and hold definitive esthetic restorations until weight has been stable for a period we agree on together.”]
I would not delay treating disease. I do think there is a conversation worth having about when to lock in the final esthetics.
I would not tell anyone to stop a medication that is improving their metabolic health because of their teeth. I would tell them to protect the environment while they take it.
I want to be straight about the limits.
There is no good evidence that GLP-1 medications directly cause cavities. There is no good evidence that they cause gum disease. The mechanisms are indirect: less saliva means less buffering, and more acid exposure means more erosion. Both of those chains are well established dentistry. What is unsettled is how often GLP-1 therapy creates the conditions, and in whom.
The picture may also cut the other way. A 2026 review in the Journal of Clinical Medicine notes that preclinical and limited clinical evidence suggests these medications may reduce periodontal inflammation, while their effects on the bone supporting your teeth remain uncertain. Improved metabolic control is good for gums. That is not in tension with monitoring for dryness and erosion. Both can be true.
Anyone telling you these drugs will ruin your teeth is overstating it. Anyone telling you there is nothing to watch is not paying attention.
Dentistry has been treated as a separate department from the rest of medicine for a long time. It is not one.
Your medications change your saliva. Your metabolic health changes your gums. Your digestion changes your enamel. Your nutrition changes the bone holding everything in place.
GLP-1 medications are a current, visible example of something restorative dentists have understood for decades. The mouth reports on the rest of the body, usually before anyone else notices.
You do not need an “Ozempic protocol.” You need your dentist to know what you are taking.
This article is for general education and is not a substitute for individual clinical evaluation. If you are taking a GLP-1 medication and have questions about your oral health, schedule a consultation or speak with your dentist.
